Viewing Study NCT00015457



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00015457
Status: COMPLETED
Last Update Posted: 2013-04-01
First Post: 2001-04-18

Brief Title: Amlodipine Plus Botulinum Toxin for Focal Dystonia
Sponsor: National Institute of Neurological Disorders and Stroke NINDS
Organization: National Institutes of Health Clinical Center CC

Study Overview

Official Title: Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia
Status: COMPLETED
Status Verified Date: 2013-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Objective To determine if the calcium channel blockers amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia

Study Population 20 patients with cervical dystonia

Design Double-bind placebo-controlled clinical trail

Outcome measures For patients dystonia rating scales Twistrs Fahn-Marsden dystonia scale NINDS subjective patient rating scale and hand grip strength For healthy volunteers Amplitude of EDB MEP
Detailed Description: Objective To determine if the calcium channel blocker amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia

Study Population 20 patients with cervical dystonia

Design Double-bind placebo-controlled clinical trail

Outcome measures dystonia rating scales TWISTRS

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
01-N-0147 OTHER NIH None